Century Therapeutics (IPSC) Return on Sales (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• Quarterly Return on Sales rose 8.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (up 19.0% YoY) and the FY2025 annual result came in at 0.0%, up 19.0% from the prior year.
• Return on Sales advanced to 0.0% in Q4 2025 per IPSC's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2025 and bottomed at 3.36% in Q2 2023.
• The 4-year median for Return on Sales is 0.28% (2024), against an average of 0.61%.
• The widest annual swing landed in 2023, when Return on Sales slumped 314 bps; it then jumped 296 bps in 2024.
• Tracing IPSC's Return on Sales over 4 years: stood at 0.61% in 2022, then plunged by 142 bps to 1.47% in 2023, then jumped by 94 bps to 0.08% in 2024, then jumped by 100 bps to 0.0% in 2025.
• Per Business Quant, the three latest IPSC Return on Sales figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).

Peer Comparison